📖
Loss of BAX in a neuroblastoma patient reveals delayed apoptosis but sustained chemotherapy sensitivity.
Molero-Valenzuela A, de Rojas-P I, Pons G, Pérez-García MJ, Guillén G, Vilaplana A, Manresa-Vera S, Pérez-Albert P, Garrido M, Valero-Arrese L, Hladun R, Sánchez-Guixé M, Miera-Maluenda M, Boloix A, Roma J, Soriano A, Moreno L, Segura MF

Loss of BAX in a neuroblastoma patient reveals delayed apoptosis but sustained chemotherapy sensitivity.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in NPJ Precis Oncol.

Advertisement
SPONSOR CONTENT
Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Loss of BAX in a neuroblastoma patient reveals delayed apoptosis but sustained chemotherapy sensitivity.
Author / Organization Molero-Valenzuela A, de Rojas-P I, Pons G, Pérez-García MJ, Guillén G, Vilaplana A, Manresa-Vera S, Pérez-Albert P, Garrido M, Valero-Arrese L, Hladun R, Sánchez-Guixé M, Miera-Maluenda M, Boloix A, Roma J, Soriano A, Moreno L, Segura MF
Subject & Discipline NPJ Precis Oncol
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-44573
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »